ITC Ltd: India's Diversified Giant Ousts BAT as Global Tobacco Leader

BAT by 2FIRSTS.ai
Dec.08.2023
ITC Ltd: India's Diversified Giant Ousts BAT as Global Tobacco Leader
India's ITC Ltd has surpassed British American Tobacco (BAT) to become the world's third-largest tobacco company.

According to a report from The Telegraph, a daily newspaper in Kolkata, India, on December 7th, Indian conglomerate ITC Ltd has become the world's third-largest tobacco company, surpassing British American Tobacco (BAT), following a significant sell-off of BAT stocks that led to a sharp decline in their share prices.

 

ITC, a company that diversified its business from tobacco to fast-moving consumer goods, hotels, paper, and agricultural products, reached a market value of $68.6 billion by the end of the trading day on December 7th. On the other hand, British American Tobacco closed at a market value of £51.58 billion (approximately $64.9 billion).

 

The ITC company was established in 1910 as the India Tobacco Company Limited. As the company's ownership gradually became more Indian, the name was changed to I.T.C. in 1970, and later renamed ITC Limited in 1974.

 

British American Tobacco (BAT), established in 1902, is a joint venture between American Tobacco Company and Imperial Tobacco Company of Great Britain. It continues to hold significant stake in India's ITC Limited. Through three entities, British and American Tobacco Companies collectively own 29.04% of ITC, which is valued at a staggering $19.9 billion.

 

British American Tobacco's stake in ITC accounts for nearly one-third of the company's market value. However, the classification of British American Tobacco's stake in ITC as foreign direct investment is problematic because India prohibits foreign direct investment in tobacco companies, which restricts British American Tobacco's options in the country.

 

British American Tobacco, a multinational tobacco company, is publicly listed on the International Tobacco Company (ITC) and has two directors representing the company's shareholders.

 

The stock of ITC has been consistently on the rise, surpassing the broader market by a significant margin. In the past year alone, it has shown an impressive growth of 34.7%, and over the course of three years, it has risen by 125.5%. Investors continue to place their bets on the company's diversified strategy, the increasing profitability of its fast-moving consumer goods business, the growth in cigarette sales, and the recovery of its hotel industry.

 

In the six months ending on September 30, 2023, the tobacco business accounted for only 37% of ITC Company's total revenue. However, it accounted for 78% of the company's pre-tax profit.

 

In contrast, the stocks of British American Tobacco hit multi-year lows on Wednesday as the company wrote off $31.5 billion of value from some of its American cigarette brands. British American Tobacco saw a decline of as much as 10% on the London Stock Exchange, reaching its lowest level since September 2010.

 

It is worth mentioning that British American Tobacco has set a target for half of its revenue to come from non-combustible products by 2035.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI U.S. to Host Job Fair for ZYN Nicotine Pouch Factory in Colorado
PMI U.S. to Host Job Fair for ZYN Nicotine Pouch Factory in Colorado
PMI U.S. plans to host a job fair to recruit employees for its ZYN nicotine pouch manufacturing facility currently under construction in Aurora, Colorado. The main position being recruited is Process Technician, responsible for equipment operation and maintenance, quality and safety monitoring, and supporting continuous production improvements.
Mar.12 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Illegal Trade in Tobacco and E-Cigarettes Continues to Rise in Germany, BVTE and BDZ Call for Enforceable Regulation
Illegal Trade in Tobacco and E-Cigarettes Continues to Rise in Germany, BVTE and BDZ Call for Enforceable Regulation
BVTE and BDZ said at a joint press conference in Berlin on March 10 that illegal trade in tobacco products, e-cigarettes and other nicotine products continues to grow in Germany, posing challenges to the rule of law, youth protection, consumer protection and state fiscal authority. The groups said there is still no reliable overall statistic for the illegal trade in tobacco products, e-cigarettes, nicotine pouches and oral nicotine products.
Mar.12 by 2FIRSTS.ai
UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
Philip Morris Japan (PMJ) announced that it will launch “SENTIA Purple Capsule,” the first capsule-equipped product in its SENTIA lineup dedicated to the heated tobacco “IQOS ILUMA” series, as an early release in Japan. The product will roll out nationwide starting from IQOS Stores, and will enter tobacco retail channels nationwide from April 6.
Mar.03 by 2FIRSTS.ai
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
France’s HAS to Address Role of E-Cigarettes in Updated Smoking-Cessation Guidelines, Tells 2Firsts
2Firsts has learned that France’s national health authority, the Haute Autorité de Santé (HAS), confirmed the role of e-cigarettes will be addressed in updated national smoking-cessation guidelines expected by the end of 2026. HAS said the recommendations will focus on clinical and public-health considerations, will not set technical standards for vaping products, and that current studies are insufficient to clearly assess risks and benefits across different product categories.
Mar.10